Noriyo YAMASHIKI

Prof. Dr. Noriyo YAMASHIKI

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2008 in Clinical Gastroenterology and Hepatology
Verified
Journal Article
Closed access
TOTakamasa Ohki
Takamasa Ohki
RTRyosuke Tateishi
Ryosuke Tateishi
TSTakahisa Sato
Takahisa Sato
RMRyota Masuzaki
Ryota Masuzaki
JIJun Imamura
Jun Imamura
MOMasao Omata
Masao Omata

22 August 2019 in BMC Gastroenterology
Verified
Journal Article
Open access
PDF file
LCLancharat Chuncharunee
Lancharat Chuncharunee
NYNoriyo YAMASHIKI
Noriyo YAMASHIKI
ATAmmarin Thakkinstian
Ammarin Thakkinstian
ASAbhasnee Sobhonslidsuk
Abhasnee Sobhonslidsuk
Alcoholic liver disease (ALD) is the leading cause of liver transplantation (LT). The magnitude and risk factors of post-LT alcohol relapse are not well described. We conducted a meta-analysis to evaluate alcohol relapse rate and its predictors after LT. Searches of MEDLINE and SCOPUS identified eligible published studies of alcohol relapse after LT published up to 31 March 2018. Alcohol relapse was defined as any alcohol consumption post-LT, and heavy alcohol relapse was defined as a relapse of alcohol consumption that was associated with a significant harm. Data for the proportion of alcohol relapse was pooled using a meta-analysis for pooling proportion. An odds ratio (OR) of the predictor of alcohol relapse was extracted and pooled using meta-analysis for the pooling risk factor. Data were analyzed using a random effect model if heterogeneity was presented; otherwise, a fixed effect model was applied. The study was registered at PROSPERO (CRD42017052659). Ninety-two studies with over 8000 cases were recruited for pooling proportion of alcohol relapse. The alcohol relapse rate and heavy alcohol relapse rate after LT during the mean follow-up time of 48.4 ± 24.7 months were 22% (95% confidence interval (CI): 19–25%) and 14% (95%CI: 12–16%). Psychiatric comorbidities (odds ratio (OR) 3.46, 95%CI: 1.87–6.39), pre-transplant abstinence of less than 6 months (OR 2.76, 95%CI: 2.10–3.61), unmarried status (OR 1.84, 95%CI: 1.39–2.43), and smoking (OR 1.72, 95%CI: 1.21–2.46) were associated with alcohol relapse after LT. However, we noticed publication bias of unpublished negative studies and high heterogeneity of results. Post-transplant alcohol relapse occurred in about one-fifth of patients who underwent alcohol-related LT. Psychiatric comorbidities represented the strongest predictor of alcohol relapse. Psychiatric comorbidities monitoring and pre-LT alcohol abstinence for at least 6 months may decrease alcohol relapse after LT.

1 June 2018 in Annals of Surgery
Verified
Journal Article
Closed access
PDF file
TKToyonari Kubota
Toyonari Kubota
KHKoichiro Hata
Koichiro Hata
TSTakashi Sozu
Takashi Sozu
YUYoshihide Ueda
Yoshihide Ueda
HHHirofumi Hirao
Hirofumi Hirao
SUShinji Uemoto
Shinji Uemoto
Objective: To investigate the influence of donor age on recipient outcome after living-donor partial liver transplantation (LDLT). Background: Donor age is a well-known prognostic factor in deceased donor liver transplantation; however, its role in LDLT remains unclear. Methods: We retrospectively analyzed 315 consecutive cases of primary adult-to-adult LDLT in our center between April 2006 and March 2014. Recipients were divided into 5 groups according to the donor age: D-20s (n = 60); D-30s (n = 72); D-40s (n = 57); D-50s (n = 94); and D-60s (n = 32). The recipient survival and the association with various clinical factors were investigated. Results: Recipient survival proportions were significantly higher in D-20s compared with all the other groups (P = 0.008, < 0.001, < 0.001, and = 0.006, vs D-30s, -40s, -50s, and -60s, respectively), whereas there was no association between recipient survival and their own age. There are 3 typical relationships between donors and recipients in adult-to-adult LDLT: from child-to-parent, between spouses/siblings, and from parent-to-child. The overall survival in child-to-parent was significantly higher than in spouses/siblings (P = 0.002) and in parent-to-child (P = 0.005), despite significantly higher recipient age in child-to-parent [59 (42–69) years, P < 0.001]. Contrastingly, parent-to-child exhibited the lowest survival, despite the youngest recipient age [26 (20–43) years, P < 0.001]. In addition, younger donor age exhibited significantly better recipient survival both in hepatitis C virus-related and in non-hepatitis C virus diseases. Univariate and multivariate analyses both demonstrated that donor age and graft-type (right-sided livers) are independent prognostic factors for recipient survival. Conclusions: Donor age is an independent, strong prognostic factor in adult-to-adult LDLT.

11 May 2012 in Liver Transplantation
Verified
Journal Article
Open access
PDF file
NYNoriyo YAMASHIKI
Noriyo YAMASHIKI
YSYasuhiko Sugawara
Yasuhiko Sugawara
STSumihito Tamura
Sumihito Tamura
NNNobuaki Nakayama
Nobuaki Nakayama
MOMakoto Oketani
Makoto Oketani
NKNorihiro Kokudo
Norihiro Kokudo
Nationwide surveys of acute liver failure (ALF) are conducted annually in Japan, and 20% of patients with ALF undergo liver transplantation (LT). We extracted data for 212 patients who underwent LT for ALF from the nationwide survey database of the Intractable Liver Diseases Study Group of Japan. After the exclusion of 3 patients who underwent deceased donor LT, 209 recipients of living donor liver transplantation (LDLT) were analyzed. ALF patients were placed into 3 subgroups according to the time from the onset of the disease to the occurrence of encephalopathy: patients who presented with encephalopathy within 10 days of the disease's onset were classified as having acute ALF, patients who presented within 11 to 56 days were classified as having subacute ALF, and patients who presented within 9 to 24 weeks were classified as having late-onset hepatic failure (LOHF). Long-term follow-up data were obtained from the registry of the Japanese Liver Transplantation Society. The 2 data sets were merged, and descriptive and survival data were analyzed. A Cox regression analysis was performed to define factors predicting overall mortality, short-term mortality (≤90 days after LT), and long-term mortality (>90 days after LT). One hundred ninety of the analyzed patients (91%) were adults (age ≥ 18 years); 70 patients (34%) were diagnosed with acute ALF, 124 (59%) were diagnosed with subacute ALF, and 15 (7%) were diagnosed with LOHF. Hepatitis B virus was the most common cause of acute ALF (61%), whereas autoimmune hepatitis (14%) and drug allergy–induced hepatitis (14%) were more frequent in patients with subacute ALF or LOHF. The cumulative patient survival rates 1, 5, and 10 years after LT were 79%, 74%, and 73%, respectively. Patient age was associated with short- and long-term mortality after LT, whereas ABO incompatibility affected short-term mortality, and donor age affected long-term mortality. In conclusion, the long-term outcomes of LDLT for ALF in this study were excellent, regardless of the etiology or classification. The majority of the donors were living donors. Increasing the deceased donor pool might be an urgent necessity. Liver Transpl, 2012. © 2012 AASLD.

12 April 2018 in Journal of Inherited Metabolic Disease
Verified
Journal Article
Closed access
PDF file
KHKiyoshi Hayasaka
Kiyoshi Hayasaka
CNChikahiko Numakura
Chikahiko Numakura
MYMitsunori Yamakawa
Mitsunori Yamakawa
TMTetsuo Mitsui
Tetsuo Mitsui
HWHisayoshi Watanabe
Hisayoshi Watanabe
HYHiroshi Yoshida
Hiroshi Yoshida

15 May 2013 in Transplantation
Verified
Journal Article
Closed access
JKJunichi Kaneko
Junichi Kaneko
YSYasuhiko Sugawara
Yasuhiko Sugawara
STSumihito Tamura
Sumihito Tamura
TATaku Aoki
Taku Aoki
YSYoshihiro Sakamoto
Yoshihiro Sakamoto
NKNorihiro Kokudo
Norihiro Kokudo
Organ transplant recipients have an increased incidence of malignancy. Race differences in a variety of malignancies are observed among the general population, but de novo malignancies after adult-to-adult living-donor liver transplantation (LDLT) have not been compared with those from a Japanese population-based study. The subjects were 360 adult LDLT recipients who survived more than 1 year after transplantation. An annual medical checkup and screening examinations were performed as follows: abdominal computed tomography or magnetic resonance imaging, upper gastrointestinal endoscopy, and total colonoscopy and immunochemical fecal occult blood test every 1 to 2 years. Complete blood count, liver function tests, and several tumor markers were checked every 1 to 3 months after LDLT. Mean follow-up period was 7.5±3.4 years. During the follow-up period, 27 de novo malignancies were diagnosed in 26 recipients. Colorectal cancer was the most commonly detected malignancy. The overall mortality of the recipients with de novo malignancies was similar to the findings of the Japanese general population-based study (standardized mortality ratio=0.9). Overall, the incidence of cancer was significantly higher in transplant recipients than in the Japanese general population (standardized incidence ratio=1.8). The 5-year estimated survival rate of recipients with de novo malignancies was 81% and those of recipients without malignancies was 93% (P<0.0001). Colorectal malignancies predominated in Japanese liver transplant recipients. Although de novo malignancies correlated with a poor prognosis, the standardized mortality ratio was 0.9 compared with that of subjects of a Japanese population-based study.